Abstract
Scopolamine hydrobromide was administered by subcutaneous injection to 30 young subjects in a dose of 0.22 mg/70 kg, 0.43 mg/70 kg, or 0.65 mg/70 kg. Treatment effects were compared to placebo on an extensive cognitive assessment battery. Almost all tests in the battery had been previously administered to Alzheimer's disease patients and nondemented elderly subjects. Scopolamine produced deficits on tests of verbal recall, visuospatial recall, visual recognition memory, visuospatial praxis, visuoperceptual function, and psychomotor speed. Immediate memory, language function, object sorting, and frequency of intrusion errors were unaffected. The low dose of scopolamine produced some peripheral anticholinergic signs but did not affect the cognitive measures. The results support the conclusion reached in previous studies that the cognitive profile of scopolamine-injected young subjects is more similar to that of the nondemented elderly than to that of Alzheimer's disease patients.
Similar content being viewed by others
References
Bartus RT, Johnson HR (1976) Short term memory in the rhesus monkey: disruption from the anticholinergic scopolamine. Pharmacol Biochem Behav 5:39–40
Bartus RT, Fleming D, Johnson HR (1978) Aging in the rhesus monkey: debilitating effects on short-term memory. J Gerontol 33:858–871
Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction: a critical review. Science 217:408–417
Beatty WW, Butters N, Janowsky DS (1986) Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia. Behav Neurol Biol 45:196–211
Benton AL, Hamsher K, Varney NR, Spreen O (1983) Contributions to neuropsychological assessment. Oxford University Press, New York
Caine ED, Weingartner H, Ludlow CL, Cudahy EA, Wehry S (1981) Qualitative analysis of scopolamine-induced amnesia. Psychopharmacology 74:74–80
Crook T, Gilbert JG, Ferris SH (1980) Operationalizing memory impairment for elderly persons: the Guild memory test. Psychol Rep 47:1315–1318
Davis KL, Mohs RC, Davis BM, Levy M, Rosenberg GS, Horvath TB, De Nigris Y, Ross A, Decker P, Rothpearl A (1981) Cholinomimetic agents and human memory: clinical studies in Alzheimer's disease and scopolamine dementia. In: Crook T, Gershon S (eds) Strategies for the development of an effective treatment for senile dementia. Mark Powley Associates, New Canaan
Deutsch JA (1971) The cholinergic synapse and the site of memory. Science 174:788–794
Drachman DA, Leavitt J (1974) Human memory and the cholinergic system: a relationship to aging? Arch Neurol 30:113–121
Dundee JW, Pandit SK (1972) Anterograde amnesic effects of pethidine, hyoscine, and diazepam in adults. Br J Pharmacol 44:140–144
Eslinger PJ, Benton AL (1983) Visuoperceptual performances in aging and dementia: clinical and theoretical implications. J Clin Neuropsychol 5:213–220
Ferris SH, Crook T, Sathananthan G, Gershon S (1976) Reaction time as a diagnostic measure of cognitive impairment in senility. J Am Geriatr Soc 24:529–533
Ferris SH, Crook T, Clark E, McCarthy M, Rae D (1980) Facial recognition memory deficits in normal aging and senile dementia. J Gerontol 35:707–714
Flicker C, Bartus RT, Crook T, Ferris SH (1984) Effects of aging and dementia upon recent visuospatial memory. Neurobiol Aging 5:275–283
Flicker C, Ferris SH, Crook T, Bartus RT (1986a) The effects of aging and dementia on concept formation as measured on an object-sorting task. Dev Neuropsychol 2:65–72
Flicker C, Ferris SH, Crook T, Bartus RT, Reisberg B (1986b) Cognitive decline in advanced age: future directions for the psychometric differentiation of normal and pathological age changes in cognitive function. Dev Neuropsychol 2:309–322
Flicker C, Ferris SH, Crook T, Bartus RT (1987a) Implications of memory and language dysfunction in the naming deficit of senile dementia. Brain Lang 31:187–200
Flicker C, Ferris SH, Crook T, Bartus RT (1987b) A visual recognition memory test for the assessment of cognitive function in aging and dementia. Exp Aging Res 13:127–132
Flicker C, Ferris SH, Crook T, Bartus RT (1989) Impaired facial recognition memory in aging and dementia. Alzheimer Disease and Associated Disorders (in press)
Fozard JL (1985) Psychology of aging — normal and pathological age differences in memory. In: Brocklehurst JC (ed) Textbook of geriatric medicine and gerontology. Churchill/Livingstone, Edinburgh
Fuld PA, Katzman R, Davies P, Terry RD (1982) Intrusions as a sign of Alzheimer dementia: chemical and pathological verification. Ann Neurol 11:155–159
Ghoneim MM, Mewaldt SP (1975) Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory. Psychopharmacologia 44:257–262
Gibson GE, Peterson C, Jenden DJ (1981) Brain acetylcholine synthesis declines with senescence. Science 214:674–676
Gilbert JG, Levee RF, Catalano FL (1968) A preliminary report on a new memory scale. Percept Mot Skills 27:277–278
Gonen JY (1970) The use of Wechsler's deterioration quotient in cases of diffuse and symmetrical cerebral atrophy. J Clin Psychol 26:174–177
Kaplan E, Goodglass H, Weintraub S (1983) Boston naming test. Lea and Febiger, Philadelphia
Ketchum JS, Sidell FR, Crowell EB, Aghajanian GK, Hayes AH (1973) Atropine, scopolamine, and Ditran: comparative pharmacology and antagonists in man. Psychopharmacologia 28:121–145
Lehman HE, Ban TA (1970) Psychometric tests in evaluation of brain pathology responsive to drugs. Geriatrics 25:142–147
Lippa AS, Critchett DS, Ehlert F, Yamamura HI, Enna SJ, Bartus RT (1981) Age-related alterations in neurotransmitter receptors: an electrophysiological and biochemical analysis. Neurobiol Aging 2:3–8
McCarthy M, Ferris SH, Clark E, Crook T (1981) Acquisition and retention of categorized material in normal aging and senile dementia. Exp Aging Res 7:127–135
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health & Human Services Task Force on Alzheimer's disease. Neurology 34:939–944
Mash DC, Flynn DD, Potter LT (1985) Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228:1115–1117
Mohs RC, Johns CA, Dunn DD, Sherman NA, Rosen WG, Davis KL (1986) Anticholinergic dementia as a model of Alzheimer's disease. In: Poon LW (ed) Handbook for clinical memory assessment of older adults. American Psychological Association, Washington (DC), pp 403–408
Nuotto E (1983) Psychomotor, physiological and cognitive effects of scopolamine and ephedrine in healthy man. Eur J Clin Pharmacol 24:603–609
Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2:1457–1459
Serby M, Corwin J, Jordan B, Novatt A, Rotrosen J (1984) Side effects of scopolamine administration. Am J Psychiatry 141:1010
Sherman KA, Kuster JE, Dean RL, Bartus RT, Friedman E (1981) Presynaptic cholinergic mechanisms in brain of aged rats with memory impairments. Neurobiol Aging 2:99–104
Sim A, Sussman I (1962) Alzheimer's disease: its natural history and differential diagnosis. J Nerv Ment Dis 135:489–499
Snodgrass JG, Vanderwart M (1980) A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity. J Exp Psychol [Hum Learn Mem] 6:174–215
Storandt M, Botwinick J, Danziger WL (1986) Longitudinal changes: patients with mild SDAT and matched healthy controls. In: Poon LW (ed) Handbook for clinical memory assessment of older adults, American Psychological Association, Washington (DC), pp 277–284
Strong RP, Hicks P, Hsu L, Bartus RT, Enna SJ (1980) Age-related alterations in the rodent brain cholinergic system and behavior. Neurobiol Aging 1:59–63
Tsui WH, Van Gelder P (1979) A general-purpose data extraction language. Behav Res Methods Instrum 11:199–204
Van Gelder P, Todd J, Tsui WH (1979) Data acquisition software for high data rate experiments. Behav Res Methods Instrum 11:192–198
Wechsler D (1955) Manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, New York
Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122–126
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Flicker, C., Serby, M. & Ferris, S.H. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacology 100, 243–250 (1990). https://doi.org/10.1007/BF02244414
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244414